U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
140851140851Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic CancerTerminatedHas ResultsInvasive Thymoma and Thymic Carcinoma|Recurrent Thymoma and Thymic Carcinoma|Stage III Thymoma|Stage IVA Thymoma|Stage IVB ThymomaDrug: saracatinibhttps://ClinicalTrials.gov/show/NCT00718809
140852140852Naturopathic Treatment for the Prevention of Cardiovascular DiseaseCompletedNo Results AvailableCardiovascular DiseaseOther: Naturopathic medicine. May include: fish oil, plant sterols, soluble fiber, cinnamon, coQ10 and exercise|Other: Conventional medical treatment (Atorvastatin,Fluvastatin,Lovastatin,Pravastatin,Rosuvastatin,Simvastatin)https://ClinicalTrials.gov/show/NCT00718796
140853140853Molecular Analysis of RetinoblastomaRecruitingNo Results AvailableRetinoblastomaOther: Tissue samples taken from retinoblastoma|Other: 5 ml peripheral bloodhttps://ClinicalTrials.gov/show/NCT00718783
140854140854A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) ExpressionCompletedHas ResultsThyroid CancerDrug: Bexarotenehttps://ClinicalTrials.gov/show/NCT00718770
140855140855Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic MalignanciesCompletedNo Results AvailableNon-Hodgkins Lymphoma|Hodgkin's Disease|Acute Lymphoblastic LeukemiaDrug: Dexamethasone|Drug: Irinotecan|Drug: Vincristinehttps://ClinicalTrials.gov/show/NCT00718757
140856140856Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP UnitsCompletedNo Results AvailableRhinitis, Allergic, Seasonal|Conjunctivitis, AllergicOther: Standardization of allergenic extract (Ch. arcuatus)https://ClinicalTrials.gov/show/NCT00718744
140857140857Study GSI-136 in Healthy Young and Healthy Elderly SubjectsCompletedNo Results AvailableAlzheimer Disease|HealthyDrug: GSI-136|Other: Placebohttps://ClinicalTrials.gov/show/NCT00718731
140858140858A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNo Results AvailableArthritis, RheumatoidDrug: CNTO 136 100 mg|Drug: CNTO 136 50 mg|Drug: CNTO 136 25 mg|Drug: Placebo|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT00718718
140859140859Reduction of Spontaneous Prematurity by Antibiotic Treatment (Josamycin)CompletedNo Results AvailablePrematurityDrug: Josamycin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00718705
140860140860Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)CompletedNo Results AvailableImmune Thrombocytopenic PurpuraBiological: Sym001https://ClinicalTrials.gov/show/NCT00718692
140861140861Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled TrialCompletedNo Results AvailableAllergy to Cat DanderDrug: IVN201|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00718679
140862140862The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy ToddlersCompletedNo Results AvailableInfections, MeningococcalBiological: Meningococcal vaccine GSK134612https://ClinicalTrials.gov/show/NCT00718666
140863140863Effects of Antioxidants on Human Macular PigmentsCompletedNo Results AvailableEye HealthDietary Supplement: Lutein|Dietary Supplement: Lutein plus green tea extracthttps://ClinicalTrials.gov/show/NCT00718653
140864140864An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney FunctionTerminatedHas ResultsMultiple MyelomaDrug: Dexamethasone|Drug: Bortezomibhttps://ClinicalTrials.gov/show/NCT00718640
140865140865Human Heterologous Liver Cells for Infusion in Children With Urea Cycle DisordersActive, not recruitingNo Results AvailableUrea Cycle Disorders|Carbamoylphosphate Synthetase I Deficiency|Ornithine Transcarbamylase Deficiency|CitrullinemiaBiological: Human Heterologous Liver Cellshttps://ClinicalTrials.gov/show/NCT00718627
140866140866Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-dependent Diabetes Mellitus (IDDM)TerminatedNo Results AvailableDiabetes Mellitus, Type 1|Diabetic RetinopathyProcedure: Light will be switched from 0.5µW/cm2/sr to 115µW/cm2/sr.https://ClinicalTrials.gov/show/NCT00718614
140867140867Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: Imetelstat Sodium (GRN163L)https://ClinicalTrials.gov/show/NCT00718601
140868140868A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid ArthritisTerminatedNo Results AvailableRheumatoid ArthritisDrug: MTRX1011Ahttps://ClinicalTrials.gov/show/NCT00718588
140869140869The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver TransplantationTerminatedNo Results AvailableLiver TransplantationProcedure: Glucose/Ischemic Preconditioning Pre-treatmenthttps://ClinicalTrials.gov/show/NCT00718575
140870140870Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and SunitinibCompletedNo Results AvailableGastrointestinal Stromal TumorsDrug: AMN107https://ClinicalTrials.gov/show/NCT00718562
140871140871A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-cell Chronic Lymphocytic LeukemiaActive, not recruitingNo Results AvailableLymphocytic Leukemia, ChronicDrug: cladribine|Drug: cyclophosphamide|Drug: rituximab [MabThera/Rituxan]|Drug: rituximab [MabThera/Rituxan]|Drug: rituximab [MabThera/Rituxan]https://ClinicalTrials.gov/show/NCT00718549
140872140872Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral TherapyCompletedNo Results AvailableHIV InfectionsDrug: Addition of raltegravir 800 mg QD to HAARThttps://ClinicalTrials.gov/show/NCT00718536
140873140873Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian CancerTerminatedNo Results AvailableOvarian NeoplasmsDrug: AMG 479|Drug: AMG 479 Placebohttps://ClinicalTrials.gov/show/NCT00718523
140874140874L-arginine in Treatment as Usual in SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: L-Argininehttps://ClinicalTrials.gov/show/NCT00718510
140875140875Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient PopulationCompletedNo Results AvailableAmyotrophic Lateral Sclerosis|Neurodegenerative Disease|Motor Neuron Diseasehttps://ClinicalTrials.gov/show/NCT00718497
140876140876A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue SarcomaActive, not recruitingNo Results AvailableSoft Tissue SarcomaDrug: Palifosfamide Tris and Doxorubicin|Drug: Doxorubicinhttps://ClinicalTrials.gov/show/NCT00718484
140877140877STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH)CompletedNo Results AvailablePrimary PCI - STEMIDrug: Enoxaparin|Drug: UFH (unfractionated heparin)https://ClinicalTrials.gov/show/NCT00718471
140878140878EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)RecruitingNo Results AvailableAmyotrophic Lateral Sclerosis|Neurodegenerative Disease|Motor Neuron Diseasehttps://ClinicalTrials.gov/show/NCT00718458
140879140879Pennsylvania Consortium: Clinical DatabaseTerminatedNo Results AvailableAmyotrophic Lateral Sclerosis|Neurodegenerative Disease|Motor Neuron Diseasehttps://ClinicalTrials.gov/show/NCT00718445
140880140880An Interventional Study of Geriatric Frailty, Osteoporosis, and DepressionCompletedNo Results AvailableFrailty|Osteoporosis|DepressionBehavioral: Exercise and nutritional integrated care|Behavioral: Usual care with education|Behavioral: Problem solving therapy (PST) integrated carehttps://ClinicalTrials.gov/show/NCT00718432

* Görseller ve İçerik tekif hakkına sahip olabilir